Human Chorionic Gonadotropin (HCG) is a protein containing a total of 237 amino acids and made up
of 2 subunits, an alpha chain and a beta chain, which are held together by the weak forces of hydrogen
bonding. Apparently, the protein activity requires the intact molecule which is lost or greatly reduced if
these subunits break apart. In addition, because of its amino acid sequence and 3-dimensional
orientation, the outer surface is highly charged ionically.
The official assay method which is spelled out in the USP, involves dosing laboratory rats, then
sacrificing them and determining the weight of their uteruses, which can be correlated to the potency of
HCG. Since this is a tedious, time consuming and distasteful process, it is not practical on a day to day
basis. One of the alternate methods which has been used to assay the concentration of HCG, is by
means of an immunoassay technique. This utilizes monoclonal antibodies that are specific to a specific
sequence of amino acids found in the beta subunit of the protein. Such a technique works best for invivo
testing because, in the body, the protein tends to maintain its structural integrity. Under in-vitro
conditions however, such as a pharmaceutical preparation, this method can produce false high values
because it will label both the intact protein as well as the disassociated beta subunit, and certain
fragments of this subunit, as if they are the active intact form. Like all proteins, HCG is fragile and can
be broken apart and denatured by processing, mechanical mixing, shaking, homogenizing, or ultrasonic
dissolution. This can occur during the supplier’s manufacturing processes as well as during
In our lab, we have developed and validated a chromatographic method which separates the intact
protein from its subunits, as well as from various peptide pieces. This allows us to correctly assay only
the intact protein concentration, which correlates well with its potency.
HCG has a tendency to adhere to plastic more than glass, primarily when in solution. This becomes
especially significant in concentrations below 1,000 units/mL. To help with this, we suggest not using
plastic materials for anything that might come into contact with the HCG solution. (As a dry powder,
this is not as critical). Also, for all glassware that will be exposed to solutions of HCG, pre-rinsing then
wasting, with some of the HCG solution will help prevent losses. Like most proteins, some of it can
adhere to filter materials. When sterile filtering, therefore, we suggest using a low-protein binding filter
and wasting the first 1-2 mL that passes through the filter, then begin dispensing into sterile containers
after that. HCG is sensitive to warm temperatures, so both in the solid form as well as in solution, it
should be stored and shipped under refrigeration. Freezing, especially freezing then thawing and
refreezing of any protein solution is not suggested because ice crystals, as they form, can damage the
molecule. In our experience, we find that when HCG is dry mixed (often with mannitol powder) it is best
accomplished by tumbling in a plastic or glass container. Like most proteins its exposure to metal
should be limited. It is best not to mix in a mortar and pestle, which can cause fragmentation of the
protein due to the inherent mechanical grinding action of this technique. And, finally, when making and
mixing solutions of HCG, do not shake or sonicate. Instead, swirl or rock the container in a smooth
action to avoid breaking the protein.
HCG Formulations Factspdf 287.93 KB 10/24/18, 4:28 PM Download
Vitamin B12 is a common nutritional supplement in many formulations. The three most often used
forms are Cyanocobalamin (B12), Methylcobalamin (Me-B12) and Hydroxocobalamin (B12a).
When formulating methylcobalamin, many are aware of its sensitivity to light but may not know just how
sensitive it is. In our lab we carried out an experiment to see just how sensitive a typical formulation
might be to typical interior lab lighting. The formulation we selected as our test sample was one
containing methylcobalamin 1000mcg/ml in normal saline plus benzyl alcohol 2%. We assayed the
sample to check its potency and found it to be 985mcg/mL so it was 98.5% potent, thus meeting
requirements. We then exposed the solution in a clear glass vial for 5 minutes under our lab’s typical
florescent lighting, then once again tested it for potency. The potency was now at 54.4%, a 44.1%
decline! Much of the active had converted to hydroxocobalamin (B12a). After another 5 minutes
exposure, now a total of 10 minutes, the potency was now down to 30.8% a 67.7% decline from the
initial potency. After a total of 15 minutes, the potency stood at 15.2%, a total decline of 83.3% from the
starting point! Clearly, methylcobalamin is VERY light sensitive and easily converts to
To maintain potency all precautions possible to protect it from light should be taken. In many labs,
amber glassware is used and this works quite well. Another possibility is to wrap all glassware with
aluminum foil. This works but is awkward because the sample cannot be inspected to make sure all of
the active has dissolved nor can volumetric graduations be seen to verify proper dilution has been
accomplished. (Please note: when weighing out the dry API powder, methylcobalamin is fairly light
stable so this step can be completed in normal room light. Once it has been put into solution however,
it becomes very light sensitive.)
We found we could prepare and test a methylcobalamin formulation successfully by turning off the lab
lights and operate by the small amount of light coming into the lab from a distant window. The work
area was quite dark, glassware graduations could just barely be read, but the technique does work,
methylcobalamin did not break down to any measurable degree. Unfortunately, others in the lab didn’t
appreciate the idea so much!
More recently, we found we could use a red light bulb in a separate area of our lab and the potency did
not decline at all, even after 15 minutes exposure time. The bulb we used was a Philips LED 8 Watt
bulb which was purchased at our local Home Depot for a very nominal cost. We repeated our
aforementioned 5, 10 and 15 minute test with this bulb as the only light source and found it worked very
well, no breakdown occured. Our analyst had plenty of light to carry out all our normal testing
procedures, could easily read glassware graduations, and best of all, didn’t upset the others!
Methylcobalamin and Lightpdf 292.74 KB 11/2/18, 9:19 PM Download
Here at Compounder’s International Analytical Laboratory we find that the vast majority of the
formulations we test are good, having potencies which fall within the required range.
Occasionally, however, a potency comes in low and we always test the sample again to see if
the number(s) change or if they repeat. If the low potency value repeats there could be several
reasons for this and among them is the presence of water or a residual solvent in the active
On the Certificate of Analysis which is supplied with the active ingredient, there is a line which
provides the % Potency of the compound. Nearly always, this potency is given on the
anhydrous basis. This means the powder was dried before it was tested, or the amount of
water or residual solvent was determined and its value was subtracted from the weight of the
powder before it was assayed and the potency determined. Per the USP, there is a maximum
allowed % Water or % Loss on Drying (LOD) for each active ingredient. Usually, this number is
less than 1% so might be ignored with little consequence. But for some actives the amount is
significant and can seriously lower the potency of the final formulation since some of the powder
weight is just water. A few examples of this include:
Azithromycin will have between 4.0 to 5.0% water
Bacitracin can have up to 5.0% LOD
Betamethasone Acetate can contain up to 4% water
Bupivacaine HCl will have between 4.0 and 6.0% water and up to 2% solvent
Ciprofloxacin will have 4.7 and 6.7% water
Clindamycin HCl contains 3.0 to 6.0% Water
Dexamethasone Sodium Phosphate can have up to 16.0% total water and alcohol
Folic Acid will contain up to 8.5% water
Levothyroxine Sodium (T4) can contain as much 11.0% water.
Liothyronine Sodium (T3) can have as much as 4.0% water
There are many more examples, but you get the idea.
When compounding, it is always a good practice to note the % Water or % LOD and to subtract
this value from the anhydrous % Potency to determine the actual “as is” potency of the active.
In the case of the T4 example above, if the anhydrous potency is 98.3% and the % Water is
9.8%, the actual potency of this powder is 88.5%, so this new value should be used to develop
the formulation. Therefore, if the required amount of T4 to make a 1:100 dilution is 1.00gram,
then divide the 1.00gram by 0.885 (88.5%) to find that the weight required to achieve the correct
concentration, which would be 1.13grams in this case.
We like to suggest that whenever a new batch of active is received, the real “as is” potency
should be calculated from the anhydrous % Potency and the % Water or % LOD and written on
the front of the container before it is placed in stock. (In fact, even when there is not a
significant % water, there might be a lower potency value anyway, such as 95% or 97%). This
written potency value would then serve as a reminder as to the actual potency of each
ingredient when being used, and the weight adjusted to obtain a more accurate formulation.
Water, Water, Everywhere!rtf 1.03 KB 10/17/18, 3:45 PM Download
Liothyronine Sodium (T3) and Levothyroxine Sodium (T4) are iodonated amino acids and are typically
formulated in microgram concentrations. These active pharmaceutical ingredients (APIs) usually
contain a significant amount of water: up to 4% in the T3 powder and up to 11% in the T4 powder. The
primary reasons for the difficulty in preparing formulations containing T3 and/or T4 arise from these 3
issues; microgram concentrations, iodination of the compound, and water.
So, what makes these 3 issues so problematic?
1. In the preparation of, lets say, a powder blend to be use for preparation of T3/T4 capsules, typically
the active(s) are mixed with microcrystalline cellulose and perhaps methyl cellulose as well, to provide
the correct dilution and desired slow release properties. Sometimes a coloring agent is also included to
provide a visual indication of completeness of mixing. Normally, these are blended according to the
technique of geometric additions and mixed/stirred in the same fashion as many of the other capsule
formulations. But, there’s just one problem. In this case, we are not blending milligram amounts of an
active, we are blending microgram amounts. If we can visualize how much 1 milligram of powder is,
then imagine how much 1/1000th of this would be. We can begin to realize it would only take a few
specks of the API powder to equal a microgram. These few specks must be evenly distributed
throughout the powder blend. It may seem counterintuitive, but it actually takes longer to evenly blend
micrograms of an ingredient than it does for milligrams. In addition, if the particle size of the API is
significantly different from that of the other ingredients, once they are well mixed they might not stay
that way. During handling, the vibrations generated in the process will cause the smaller particles to
move toward the bottom of the container while the larger one will migrate to the top. (Consider what we
observe when we open a new box of granola cereal. The big clusters are usually at the top while the
crumbs are at the bottom).
2. Those that took general and/or organic chemistry class in school may recall the halogens, listed
near the right hand column of the periodic table, tend to be strongly electronegative because of their
electron rich outer shell orbital. T3 and T4 both contain iodine atoms, members of this halogen group.
If the powder blend described above is accomplished in a plastic container, the agitation of the cellulose
along with the T3/T4 actives will develop a strong static charge on the walls of the container which will
attract these microgram amounts of ingredients out of the powder and onto the surface of the container.
The more rapidly the powder blend is mixed, the stronger the static charge. In our practice we have
observed a prominent light brown color of the T4 powder clinging to the container and when we have
tested the wall scrapings, they were 30-40% higher in both the T3 and the T4 than within the main
volume of powder.
3. Since a fairly significant portion of the weight of the T3 and T4 powder is water (up to 4% and 11%
respectively), adjustments in the desired amounts of these ingredients must be made to account for
this. (See our article entitled “Water, Water Everywhere”). Unless an appropriate extra amount of the
API powder is included in the formulation, the final product will be sub potent.
Formulations containing microgram amounts of T3 and or T4 actives must be blended longer and more
completely than usual so as to account for these very low concentrations. The blending should be
accomplished in either glass or metal containers, not plastic, and should have a tumbling action of side
over side and end over end to make sure the actives are well mixed. Mortar and pestle mixing seldom
will be sufficient. The time required will vary depending upon batch size and mixing speed, but a 2 hour
mixing time would not be unusual. Ideally, both the active and inert (excipient) ingredients are
micronized to approximately the same particle size to prevent size stratification within the batch once
the blend is finished. And finally, care should be taken to account for the % water content in the API